瑞波西汀治疗下边缘性症状的恶化。 - Suppr

Suppr

超能文献

Worsening of borderline symptoms under reboxetine treatment.

作者信息

Anghelescu Ion, Jänen Britta, Schindler Frank, Lammers Claas-Hinrich

出版信息

J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):559-60. doi: 10.1176/jnp.17.4.559.

DOI:10.1176/jnp.17.4.559

PMID:16388001

Abstract

摘要

相似文献

Worsening of borderline symptoms under reboxetine treatment.

J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):559-60. doi: 10.1176/jnp.17.4.559.

Reboxetine as a potentially effective treatment for attention deficit hyperactivity disorder.

J Child Adolesc Psychopharmacol. 2001 Summer;11(2):203-4. doi: 10.1089/104454601750284135.

Reboxetine may be helpful in the treatment of amphetamine withdrawal.

Br J Clin Pharmacol. 2004 Jul;58(1):100-1. doi: 10.1111/j.1365-2125.2004.02094.x.

Reboxetine treatment of depression in Parkinson's disease.

J Clin Psychiatry. 2000 Nov;61(11):872. doi: 10.4088/jcp.v61n1111a.

Reversal of tetrabenazine induced depression by selective noradrenaline (norepinephrine) reuptake inhibition.

J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):550. doi: 10.1136/jnnp.67.4.550.

Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trial.

Clin Neuropharmacol. 2013 Mar-Apr;36(2):37-41. doi: 10.1097/WNF.0b013e31828003c1.

Reboxetine--another new antidepressant.

Drug Ther Bull. 1998 Nov;36(11):86-8.

Use of reboxetine in bulimia nervosa: a pilot study.

J Psychopharmacol. 2004 Sep;18(3):423-8. doi: 10.1177/026988110401800314.

Introduction. Reboxetine: a new selective antidepressant for the treatment of depression.

J Clin Psychiatry. 1998;59 Suppl 14:3.

An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder.

J Child Adolesc Psychopharmacol. 2008 Apr;18(2):179-84. doi: 10.1089/cap.2006.0034.

引用本文的文献

Noradrenergic enhancement of amygdala responses to fear.

Soc Cogn Affect Neurosci. 2009 Jun;4(2):119-26. doi: 10.1093/scan/nsn049. Epub 2009 Feb 25.

Noradrenergic-glucocorticoid mechanisms in emotion-induced amnesia: from adaptation to disease.

Psychopharmacology (Berl). 2008 Mar;197(1):13-23. doi: 10.1007/s00213-007-1002-x. Epub 2007 Nov 23.

Medications in the treatment of borderline personality disorder 2006.

Curr Psychiatry Rep. 2007 Feb;9(1):53-62. doi: 10.1007/s11920-007-0010-1.

Enhanced emotion-induced amnesia in borderline personality disorder.

Psychol Med. 2007 Jul;37(7):971-81. doi: 10.1017/S0033291706009792. Epub 2007 Jan 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Worsening of borderline symptoms under reboxetine treatment.

J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):559-60. doi: 10.1176/jnp.17.4.559.

Reboxetine as a potentially effective treatment for attention deficit hyperactivity disorder.

J Child Adolesc Psychopharmacol. 2001 Summer;11(2):203-4. doi: 10.1089/104454601750284135.

Reboxetine may be helpful in the treatment of amphetamine withdrawal.

Br J Clin Pharmacol. 2004 Jul;58(1):100-1. doi: 10.1111/j.1365-2125.2004.02094.x.

Reboxetine treatment of depression in Parkinson's disease.

J Clin Psychiatry. 2000 Nov;61(11):872. doi: 10.4088/jcp.v61n1111a.

Reversal of tetrabenazine induced depression by selective noradrenaline (norepinephrine) reuptake inhibition.

J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):550. doi: 10.1136/jnnp.67.4.550.

Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trial.

Clin Neuropharmacol. 2013 Mar-Apr;36(2):37-41. doi: 10.1097/WNF.0b013e31828003c1.

Reboxetine--another new antidepressant.

Drug Ther Bull. 1998 Nov;36(11):86-8.

Use of reboxetine in bulimia nervosa: a pilot study.

J Psychopharmacol. 2004 Sep;18(3):423-8. doi: 10.1177/026988110401800314.

Introduction. Reboxetine: a new selective antidepressant for the treatment of depression.

J Clin Psychiatry. 1998;59 Suppl 14:3.

An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder.

J Child Adolesc Psychopharmacol. 2008 Apr;18(2):179-84. doi: 10.1089/cap.2006.0034.

引用本文的文献

Noradrenergic enhancement of amygdala responses to fear.

Soc Cogn Affect Neurosci. 2009 Jun;4(2):119-26. doi: 10.1093/scan/nsn049. Epub 2009 Feb 25.

Noradrenergic-glucocorticoid mechanisms in emotion-induced amnesia: from adaptation to disease.

Psychopharmacology (Berl). 2008 Mar;197(1):13-23. doi: 10.1007/s00213-007-1002-x. Epub 2007 Nov 23.

Medications in the treatment of borderline personality disorder 2006.

Curr Psychiatry Rep. 2007 Feb;9(1):53-62. doi: 10.1007/s11920-007-0010-1.

Enhanced emotion-induced amnesia in borderline personality disorder.

Psychol Med. 2007 Jul;37(7):971-81. doi: 10.1017/S0033291706009792. Epub 2007 Jan 16.